Literature DB >> 15645260

Demyelination in canine distemper virus infection: a review.

Marc Vandevelde1, Andreas Zurbriggen.   

Abstract

Canine distemper virus (CDV) causes severe immunosuppression and neurological disease in dogs, associated with demyelination, and is a model for multiple sclerosis in man. In the early stage of the infection, demyelination is associated with viral replication in the white matter. In acute demyelinating lesions there is massive down-regulation of myelin transcription and metabolic impairment of the myelin-producing cells, but there is no evidence that these cells are undergoing apoptosis or necrosis. Oligodendroglial change is related to restricted infection of these cells (transcription but no translation) and marked activation of microglial cells in acute lesions. Concomitant with immunological recovery during the further course of the disease, inflammation occurs in the demyelinating plaques with progression of the lesions in some animals. A series of experiments in vitro suggests that chronic inflammatory demyelination is due to a bystander mechanism resulting from interactions between macrophages and antiviral antibodies. Autoimmune reactions are also observed, but do not correlate with the course of the disease. The progressive or relapsing course of the disease is associated with viral persistence in the nervous system. Persistence of CDV in the brain appears to be favored by non-cytolytic selective spread of the virus and restricted infection, in this way escaping immune surveillance in the CNS. The CDV Fusion protein appears to play an important role in CDV persistence. Similarities between canine distemper and rodent models of virus-induced demyelination are discussed.

Entities:  

Mesh:

Year:  2005        PMID: 15645260     DOI: 10.1007/s00401-004-0958-4

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  39 in total

1.  Canine distemper virus uses both the anterograde and the hematogenous pathway for neuroinvasion.

Authors:  Penny A Rudd; Roberto Cattaneo; Veronika von Messling
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.

Authors:  Mitchell R Emerson; Ryan J Gallagher; Janet G Marquis; Steven M LeVine
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

Review 3.  Within host RNA virus persistence: mechanisms and consequences.

Authors:  Richard E Randall; Diane E Griffin
Journal:  Curr Opin Virol       Date:  2017-03-17       Impact factor: 7.090

Review 4.  White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis.

Authors:  Melissa Cambron; Miguel D'Haeseleer; Guy Laureys; Ralph Clinckers; Jan Debruyne; Jacques De Keyser
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-04       Impact factor: 6.200

5.  SLAM- and nectin-4-independent noncytolytic spread of canine distemper virus in astrocytes.

Authors:  Lisa Alves; Mojtaba Khosravi; Mislay Avila; Nadine Ader-Ebert; Fanny Bringolf; Andreas Zurbriggen; Marc Vandevelde; Philippe Plattet
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

6.  Infectious Progression of Canine Distemper Virus from Circulating Cerebrospinal Fluid into the Central Nervous System.

Authors:  Akiko Takenaka; Hiroki Sato; Fusako Ikeda; Misako Yoneda; Chieko Kai
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

7.  Deduced sequences of the membrane fusion and attachment proteins of canine distemper viruses isolated from dogs and wild animals in Korea.

Authors:  Chae-Wun Bae; Joong-Bok Lee; Seung-Yong Park; Chang-Seon Song; Nak-Hyung Lee; Kun-Ho Seo; Young-Sun Kang; Choi-Kyu Park; In-Soo Choi
Journal:  Virus Genes       Date:  2013-04-27       Impact factor: 2.332

8.  Canine distemper virus persistence in demyelinating encephalitis by swift intracellular cell-to-cell spread in astrocytes is controlled by the viral attachment protein.

Authors:  Gaby Wyss-Fluehmann; Andreas Zurbriggen; Marc Vandevelde; Philippe Plattet
Journal:  Acta Neuropathol       Date:  2010-02-02       Impact factor: 17.088

9.  Pharmacological and genetic characterisation of the canine P2X4 receptor.

Authors:  Reece A Sophocleous; Tracey Berg; Rocio K Finol-Urdaneta; Vanessa Sluyter; Shikara Keshiya; Lachlan Bell; Stephen J Curtis; Belinda L Curtis; Aine Seavers; Rachael Bartlett; Mark Dowton; Leanne Stokes; Lezanne Ooi; Ronald Sluyter
Journal:  Br J Pharmacol       Date:  2020-03-10       Impact factor: 8.739

Review 10.  Potential triggers of MS.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Results Probl Cell Differ       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.